1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cancer Immunotherapy Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Therapy Type
6.1 Monoclonal Antibodies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Cancer Vaccines
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Checkpoint Inhibitors
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Immunomodulators
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Application
7.1 Lung Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Breast Cancer
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Colorectal Cancer
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Melanoma
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Prostate Cancer
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Head and Neck Cancer
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cancer Research Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Amgen Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AstraZeneca plc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bayer AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bristol-Myers Squibb Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Eli Lilly and Company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 GSK plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Johnson & Johnson
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Merck KGaA
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Novartis AG
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Pfizer Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Sanofi S.A
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13 Seagen Inc.
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Cancer Immunotherapy Market: Major Drivers and Challenges
Figure 2: Global: Cancer Immunotherapy Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Cancer Immunotherapy Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Cancer Immunotherapy Market: Breakup by Therapy Type (in %), 2024
Figure 5: Global: Cancer Immunotherapy Market: Breakup by Application (in %), 2024
Figure 6: Global: Cancer Immunotherapy Market: Breakup by End User (in %), 2024
Figure 7: Global: Cancer Immunotherapy Market: Breakup by Region (in %), 2024
Figure 8: Global: Cancer Immunotherapy (Monoclonal Antibodies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Cancer Immunotherapy (Monoclonal Antibodies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Cancer Immunotherapy (Cancer Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Cancer Immunotherapy (Cancer Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Cancer Immunotherapy (Checkpoint Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Cancer Immunotherapy (Checkpoint Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Cancer Immunotherapy (Immunomodulators) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Cancer Immunotherapy (Immunomodulators) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Cancer Immunotherapy (Other Therapy Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Cancer Immunotherapy (Other Therapy Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Cancer Immunotherapy (Lung Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Cancer Immunotherapy (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Cancer Immunotherapy (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Cancer Immunotherapy (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Cancer Immunotherapy (Colorectal Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Cancer Immunotherapy (Colorectal Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Cancer Immunotherapy (Melanoma) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Cancer Immunotherapy (Melanoma) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Cancer Immunotherapy (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Cancer Immunotherapy (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Cancer Immunotherapy (Head and Neck Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Cancer Immunotherapy (Head and Neck Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Cancer Immunotherapy (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Cancer Immunotherapy (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Cancer Immunotherapy (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Cancer Immunotherapy (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Cancer Immunotherapy (Cancer Research Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Cancer Immunotherapy (Cancer Research Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Cancer Immunotherapy (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Cancer Immunotherapy (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Cancer Immunotherapy (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Cancer Immunotherapy (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: North America: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: North America: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: United States: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: United States: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Canada: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Canada: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Asia-Pacific: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Asia-Pacific: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: China: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: China: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Japan: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Japan: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: India: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: India: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: South Korea: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: South Korea: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Australia: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Australia: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Indonesia: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Indonesia: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Others: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Others: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Europe: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Europe: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Germany: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Germany: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: France: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: France: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: United Kingdom: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: United Kingdom: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Italy: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Italy: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Spain: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Spain: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Russia: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Russia: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Latin America: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Latin America: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Brazil: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Brazil: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Mexico: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Mexico: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Others: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Others: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Middle East and Africa: Cancer Immunotherapy Market: Sales Value (in Million USD), 2019 & 2024
Figure 87: Middle East and Africa: Cancer Immunotherapy Market: Breakup by Country (in %), 2024
Figure 88: Middle East and Africa: Cancer Immunotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Global: Cancer Immunotherapy Industry: SWOT Analysis
Figure 90: Global: Cancer Immunotherapy Industry: Value Chain Analysis
Figure 91: Global: Cancer Immunotherapy Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Cancer Immunotherapy Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Cancer Immunotherapy Market Forecast: Breakup by Therapy Type (in Million USD), 2025-2033
Table 3: Global: Cancer Immunotherapy Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Cancer Immunotherapy Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 5: Global: Cancer Immunotherapy Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Cancer Immunotherapy Market: Competitive Structure
Table 7: Global: Cancer Immunotherapy Market: Key Players